FDA Authorizes Pfizer COVID-19 Booster Shots For Children Ages 5 To 11The U.S. Food and Drug Administration has granted emergency use authorization for a booster dose of Pfizer/BioNTech's COVID-19 vaccine for children ages 5 to 11 at least five months after completion of the primary vaccine series.
FDA OKs Second COVID-19 Booster Shots For Adults Age 50 And OlderThe U.S. Food and Drug Administration has expanded the emergency use authorization of the Pfizer and Moderna COVID-19 vaccines to allow adults age 50 and older to get a second booster as early as four months after their first booster dose of any COVID-19 vaccine.
FDA Expected To OK Additional COVID-19 Booster Shots This Week For Adults Over 50The Biden administration is expected to give older adults the option of getting a second COVID-19 vaccine booster as early as this week.
Pfizer Begins Phase 2 And 3 Trial Of COVID-19 Antiviral Paxlovid In Children Ages 6 To 17The study will evaluate the safety and efficacy of the treatment in children who have COVID-19 symptoms and a confirmed infection, who are not hospitalized and who are at risk of severe disease.
Pfizer Asks FDA To Authorize COVID-19 Vaccine For Children Under 5Pfizer and BioNTech are requesting emergency use authorization for their two-dose Covid-19 vaccine for children age 6 months up to 5 years.
Detroit Offers COVID-19 Booster Shots To 16, 17-Year-OldsThe city of Detroit is offering Pfizer booster shots to eligible Detroiters, 16 and up following approval by the Centers for Disease Control.
FDA Authorizes Pfizer COVID-19 Vaccine Boosters For Ages 16-17About 2.6 million U.S. teens in this age group would be eligible for boosters already -- a small addition to the 141 million adults already eligible for boosters.
CDC Vaccine Advisers Vote To Recommend COVID-19 Boosters For All AdultsVaccine advisers to the US Centers for Disease Control and Prevention voted unanimously, 11-0, to recommend booster doses of Pfizer/BioNTech's and Moderna's COVID-19 vaccine for all adults.
Pfizer Seeks FDA Emergency Use Authorization For Its Experimental COVID-19 Antiviral PillPfizer announced it is seeking emergency use authorization from the U.S. Food and Drug Administration for its experimental antiviral COVID-19 pill, known as PF-07321332 or Paxlovid.
Pfizer, BioNTech Seek FDA Authorization For COVID-19 Vaccine Booster For All AdultsPfizer and BioNTech said on Tuesday they're seeking emergency use authorization from the US Food and Drug Administration for a COVID-19 vaccine booster for all individuals age 18 and older.
CDC Advisers Vote To Recommend Giving COVID-19 Vaccine To Kids Ages 5 To 11Members of CDC's Advisory Committee on Immunization Practices voted 14-0 to recommend the vaccine for the younger children.